Lora Hamuro

3.5k total citations · 1 hit paper
47 papers, 2.7k citations indexed

About

Lora Hamuro is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Lora Hamuro has authored 47 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Immunology. Recurrent topics in Lora Hamuro's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Biosimilars and Bioanalytical Methods (13 papers) and Chemical Synthesis and Analysis (9 papers). Lora Hamuro is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Biosimilars and Bioanalytical Methods (13 papers) and Chemical Synthesis and Analysis (9 papers). Lora Hamuro collaborates with scholars based in United States, Germany and Sweden. Lora Hamuro's co-authors include Andrew D. Hamilton, Steven J. Geib, Srilatha Raghuram, Pengxiang Huang, Thomas P. Burris, Yongjun Wang, Fraydoon Rastinejad, Vikas Chandra, William F. DeGrado and Hyung Soon Park and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Lora Hamuro

46 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA

2008 626 citations Lora Hamuro et al. Nature profile →

Peers

Countries citing papers authored by Lora Hamuro

Since Specialization

Citations

This map shows the geographic impact of Lora Hamuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora Hamuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora Hamuro more than expected).

Fields of papers citing papers by Lora Hamuro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora Hamuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora Hamuro. The network helps show where Lora Hamuro may publish in the future.

Co-authorship network of co-authors of Lora Hamuro

This figure shows the co-authorship network connecting the top 25 collaborators of Lora Hamuro. A scholar is included among the top collaborators of Lora Hamuro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora Hamuro. Lora Hamuro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic and Exposure–Response Modeling Support Body Surface Area‐Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors 2025 ·The Journal of Clinical Pharmacology ·Seiichi Hayato, Lora Hamuro, Toshio Shimizu, Kan Yonemori, Shin Nishio, (unknown), (unknown), Makoto Nishio, Koji Matsumoto, Kazuhiro Takehara, Kosei Hasegawa, (unknown), Yasuyuki Hirashima, Hidenori Kato, Takuma Miura, (unknown), Yue Zhao, Li Zhu, Sanae Yasuda	1
2	Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors 2025 ·Journal for ImmunoTherapy of Cancer ·Blessie Elizabeth Nelson, Shaun O’Brien, Rahul A. Sheth, David S. Hong, Aung Naing, Xiao–Ping Zhang, Amy Xu, Lora Hamuro, (unknown), (unknown), Ruslan D. Novosiadly, Sarina A. Piha‐Paul	6
3	IQ Survey Results on Current Industry Practices: Part 2—Quantitative Evaluations of Immunogenicity Assessment 2025 ·Clinical Pharmacology & Therapeutics ·Susan Richards, (unknown), (unknown), (unknown), Lora Hamuro, Karey Kowalski, Jocelyn H. Leu, Jianning Yang, (unknown), (unknown), Ivelina Gueorguieva, Nael M. Mostafa, Christine Grimaldi, Benjamin Wu	1
4	Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations—Going beyond the body‐size effect 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), Yue Zhao, (unknown), Lora Hamuro, Jun Shen, Amit Roy, Li Zhu	3
5	Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1 2019 ·The AAPS Journal ·Lora Hamuro, Giridhar Tirucherai, (unknown), Akbar Nayeem, Renuka Pillutla, Binodh DeSilva, Tarek A. Leil, Craig J. Thalhauser	14
6	Perspectives on Subcutaneous Route of Administration as an Immunogenicity Risk Factor for Therapeutic Proteins 2017 ·Journal of Pharmaceutical Sciences ·Lora Hamuro, Grzegorz Kijanka, Francis Kinderman, Harald Kropshofer, (unknown), Monica L. Zepeda, Vibha Jawa	63
7	Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform 2016 ·The AAPS Journal ·Rong Liu, (unknown), Shannon Chilewski, (unknown), Uma Kavita, (unknown), Carol Gleason, Yan Zhang, Renuka Pillutla, Binodh DeSilva, Lora Hamuro	4
8	Development and validation of a liquid chromatography tandem mass spectrometry assay for the quantitation of a protein therapeutic in cynomolgus monkey serum 2015 ·Journal of Chromatography B ·Yue Zhao, Guowen Liu, (unknown), Lora Hamuro, Kevin J. Trouba, Bonnie Wang, Renuka Pillutla, Binodh DeSilva, Mark E. Arnold, Jim X Shen	8
9	The effect of the neonatal Fc receptor on human IgG biodistribution in mice 2014 ·mAbs ·Nancy Chen, Weirong Wang, (unknown), Yulin Fang, Lora Hamuro, Azher Hussain, Thomayant Prueksaritanont	43
10	Lymphatic Transport and Catabolism of Therapeutic Proteins after Subcutaneous Administration to Rats and Dogs 2012 ·Drug Metabolism and Disposition ·Weirong Wang, Nancy Chen, Xiaolan Shen, Paul Cunningham, (unknown), (unknown), Bo Wang, Xuening Hong, C. M. Adreani, Christian Nunes da Silva, (unknown), Kuo‐Chang Yin, (unknown), Yan Zou, Liming Liu, Lora Hamuro, Thomayant Prueksaritanont	69
11	Pharmacokinetics of IgG1 monoclonal antibodies produced in humanized Pichia pastoris with specific glycoforms: A comparative study with CHO produced materials 2011 ·Biologicals ·Li Liu, (unknown), Lora Hamuro, Tamara Pittman, Weirong Wang, Dongxing Zha, Jerome Hochman, Thomayant Prueksaritanont	57
12	Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences 2011 ·Drug Metabolism and Disposition ·Weirong Wang, Ping Lü, Yulin Fang, Lora Hamuro, Tamara Pittman, Brian I. Carr, Jerome Hochman, Thomayant Prueksaritanont	143
13	Optimization of a Polyglutamine Aggregation Inhibitor Peptide (QBP1) Using a Thioflavin T Fluorescence Assay 2007 ·Assay and Drug Development Technologies ·Lora Hamuro, Guangtao Zhang, T. J. Tucker, Christopher R. Self, Warren J. Strittmatter, James R. Burke	11
14	Crystal structures of catalytic complexes of the oxidative DNA/RNA repair enzyme AlkB 2006 ·Nature ·Bomina Yu, W. Edstrom, Jordi Benach, Lora Hamuro, Patricia C Weber, Brian R. Gibney, J.F. Hunt	191
15	Distinct interaction modes of an AKAP bound to two regulatory subunit isoforms of protein kinase A revealed by amide hydrogen/deuterium exchange 2005 ·Protein Science ·Lora Hamuro, Jack S. Kim, Paul A. Sigala, (unknown), David D. Stranz, Patricia A. Jennings, Susan S. Taylor, Virgil L. Woods	56
16	Identification and Functional Analysis of Dual-Specific A Kinase-Anchoring Protein-2 2004 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Lora Hamuro, (unknown), Susan S. Taylor	10
17	Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: A disease susceptibility polymorphism 2003 ·Proceedings of the National Academy of Sciences ·Stefan Kammerer, Lora Hamuro, Yuliang Ma, Sara Hamon, Jaume M. Cánaves, Michael Shi, Matthew R. Nelson, Charles F. Sing, Charles R. Cantor, Susan S. Taylor, Andreas Braun	80
18	Domain Organization of D-AKAP2 Revealed by Enhanced Deuterium Exchange-Mass Spectrometry (DXMS) 2002 ·Journal of Molecular Biology ·Lora Hamuro, (unknown), Jaume M. Cánaves, Ross C. Hoffman, Susan S. Taylor, Virgil L. Woods	64
19	The twists and turns of β‐peptides 1999 ·Journal of Peptide Research ·William F. DeGrado, Joel P. Schneider, Lora Hamuro	156
20	Protein surface recognition by synthetic agents: Design and structural requirements of a family of artificial receptors that bind to cytochrome C 1998 ·Biopolymers ·Qing Lin, Hyung Soon Park, Lora Hamuro, (unknown), Andrew D. Hamilton	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact